Dr. Clay Siegall And His Dedication For Treating Serious Illnesses

Dr. Clay Siegall had founded Seattle Genetics and led it towards success in terms of providing targeted therapies for patients who crucially need serious treatment over diseases such as cancer. He is considered as a legend in the biotech field for proving that targeted therapies can provide relief to cancer patients as well. He was also responsible for developing ways to create successful drugs in the pharmaceutical industry, and for creating an FDA-approved antibody-drug conjugate, He also made partnerships with long-standing pharmaceutical companies such as Pfizer and Bayer.

Dr. Siegall was actually inspired in building all of these due to his pure interest in medicine. Every successful person gained huge profits over the things they love to do, and Dr. Siegall is one of them. He is always interested in how medicine works and how technology played a huge part in it. He also states that he has the drive to get rid of overcoming diseases, and he turned it into a goal in his life for the sake of other people. He also wants to give hope to people who are suffering from diseases that most think as a “dead-end” in one’s life. This gave him a love for studying medicine to the point where he attained the highest possible education in a certain field of science.

His belief in having a better way to treat diseases aside from extreme surgical methods such as amputation is what caused him to begin Seattle Genetics. This also became the reason why he never ended researching for medicine improvements. That’s why his company became a very valuable asset in the field of medicine and biotech nowadays. This just shows that dedication is what drives a person towards his dreams, as it contains a purpose that benefits others as well.

About Dr. Clay Siegall

Dr. Clay Siegall is the CEO of Seattle Genetics. He also stands as the founder of this Seattle-based firm in the biotech industry since 1998. It is a company which aims to provide therapies and its respective drug in order to treat serious diseases that seem to have no improvement in terms of mortality rates for patients. As a degree holder of Zoology from the University of Maryland, and a doctorate degree holder in Genetics from George Washington University, Dr. Siegall is dedicated to providing the best treatments possible for patients suffering from fatal illnesses such as cancer.